ASP4345

· Astellas Pharma Global Development, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ASP4345, covering 2020-10-27 to 2024-10-31. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP4345 in Patients With Schizophrenia [Phase 1]

See pricing